{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:59:11Z","timestamp":1778799551949,"version":"3.51.4"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["M117-F1"],"award-info":[{"award-number":["M117-F1"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stoneygate Trust"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ejca.2018.07.123","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T03:51:10Z","timestamp":1534823470000},"page":"52-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Annexin A1 regulates EGFR activity and alters EGFR-containing tumour-derived exosomes in head and\u00a0neck cancers"],"prefix":"10.1016","volume":"102","author":[{"given":"N.","family":"Raulf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6079-1623","authenticated-orcid":false,"given":"P.","family":"Lucarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5720-7422","authenticated-orcid":false,"given":"S.","family":"Thavaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Vicencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9779-7666","authenticated-orcid":false,"given":"M.","family":"Tavassoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejca.2018.07.123_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3322\/caac.21384","article-title":"The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012","volume":"67","author":"Shield","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ejca.2018.07.123_bib2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bjorl.2015.10.009","article-title":"Impact of delay in the diagnosis and treatment of head and neck cancer","volume":"82","author":"Felippu","year":"2016","journal-title":"Braz J Otorhinolaryngol"},{"issue":"5","key":"10.1016\/j.ejca.2018.07.123_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/ijc.29397","article-title":"MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and\u00a0enhancing radioresistance","volume":"137","author":"Suh","year":"2015","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2018.07.123_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/gb-2004-5-4-219","article-title":"The annexins","volume":"5","author":"Moss","year":"2004","journal-title":"Gen Biol"},{"issue":"3","key":"10.1016\/j.ejca.2018.07.123_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/jmbi.2000.4423","article-title":"X-ray structure of full-length annexin 1 and implications for membrane aggregation","volume":"306","author":"Rosengarth","year":"2001","journal-title":"J Mol Biol"},{"issue":"Pt 13","key":"10.1016\/j.ejca.2018.07.123_bib6","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1242\/jcs.01245","article-title":"Annexins\u2013unique membrane binding proteins with diverse functions","volume":"117","author":"Rescher","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ejca.2018.07.123_bib7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fimmu.2012.00354","article-title":"Annexin A1 and the regulation of innate and adaptive immunity","volume":"3","author":"Gavins","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejca.2018.07.123_bib8","doi-asserted-by":"crossref","first-page":"29660","DOI":"10.1038\/srep29660","article-title":"Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of formyl peptide receptor pathway","volume":"6","author":"Belvedere","year":"2016","journal-title":"Sci Rep"},{"issue":"46","key":"10.1016\/j.ejca.2018.07.123_bib9","doi-asserted-by":"crossref","first-page":"35202","DOI":"10.1074\/jbc.M606406200","article-title":"Requirement for annexin A1 in plasma membrane repair","volume":"281","author":"McNeil","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.ejca.2018.07.123_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bbrc.2011.03.067","article-title":"Proteomics analysis of starved cells revealed Annexin A1 as an important regulator of autophagic degradation","volume":"407","author":"Kang","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.ejca.2018.07.123_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/09687688.2012.693210","article-title":"Do annexins participate in lipid messenger mediated intracellular signaling? A question revisited","volume":"29","author":"Bandorowicz-Pikula","year":"2012","journal-title":"Mol Membr Biol"},{"issue":"9","key":"10.1016\/j.ejca.2018.07.123_bib12","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1096\/fj.05-5319fje","article-title":"Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface","volume":"20","author":"Solito","year":"2006","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.ejca.2018.07.123_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/CS20150415","article-title":"Annexin A1 localization and its relevance to cancer","volume":"130","author":"Boudhraa","year":"2016","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"10.1016\/j.ejca.2018.07.123_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7785\/tcrt.2012.500248","article-title":"High-throughput screening of saliva for early detection of oral cancer: a pilot study","volume":"11","author":"Szanto","year":"2012","journal-title":"Technol Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.ejca.2018.07.123_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.oraloncology.2013.01.002","article-title":"Annexin A1 down-regulation in oral squamous cell carcinoma correlates to pathological differentiation grade","volume":"49","author":"Zhu","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ejca.2018.07.123_bib16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1186\/1471-2407-14-961","article-title":"Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells","volume":"14","author":"Belvedere","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2018.07.123_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12916-015-0392-6","article-title":"Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis","volume":"13","author":"Sobral-Leite","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.ejca.2018.07.123_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.virol.2016.05.016","article-title":"HPV16 E6 regulates annexin 1 (ANXA1) protein expression in cervical carcinoma cell lines","volume":"496","author":"Calmon","year":"2016","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.ejca.2018.07.123_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12032-014-0327-7","article-title":"Increased expression of annexin A1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotype","volume":"31","author":"Lin","year":"2014","journal-title":"Med Oncol"},{"issue":"1\u20132","key":"10.1016\/j.ejca.2018.07.123_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1024153431272","article-title":"Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer","volume":"248","author":"Vishwanatha","year":"2003","journal-title":"Mol Cell Biochem"},{"issue":"7","key":"10.1016\/j.ejca.2018.07.123_bib21","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.bbamcr.2012.12.006","article-title":"Disruption of the annexin A1\/S100A11 complex increases the migration and clonogenic growth by dysregulating epithelial growth factor (EGF) signaling","volume":"1833","author":"Poeter","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.ejca.2018.07.123_bib22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"issue":"11","key":"10.1016\/j.ejca.2018.07.123_bib23","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/bjc.2016.336","article-title":"Downregulation of EGFR in hypoxic, diffusion-limited areas of squamous cell carcinomas of the head and neck","volume":"115","author":"Mayer","year":"2016","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2018.07.123_bib24","doi-asserted-by":"crossref","first-page":"e63440","DOI":"10.1371\/journal.pone.0063440","article-title":"Overexpression of EGFR in head and neck squamous cell carcinoma is associated with inactivation of SH3GL2 and CDC25A genes","volume":"8","author":"Maiti","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2018.07.123_bib25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.critrevonc.2015.12.006","article-title":"EGFR monoclonal antibodies in locally advanced head and neck squamous cell carcinoma: What is their current role?","volume":"99","author":"Alorabi","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.ejca.2018.07.123_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ijc.2910450124","article-title":"EGF and TGF-alpha, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors","volume":"45","author":"Yoshida","year":"1990","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2018.07.123_bib27","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.9025.1","article-title":"EGF receptor ligands: recent advances","volume":"5","author":"Singh","year":"2016","journal-title":"F1000Res"},{"issue":"17","key":"10.1016\/j.ejca.2018.07.123_bib28","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1158\/0008-5472.CAN-15-0989","article-title":"Ligand-independent EGFR signaling","volume":"75","author":"Guo","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2018.07.123_bib29","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.1038\/ncomms6811","article-title":"Constitutive and ligand-induced EGFR signalling triggers distinct and mutually exclusive downstream signalling networks","volume":"5","author":"Chakraborty","year":"2014","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.ejca.2018.07.123_bib30","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm.3388","article-title":"The quest to overcome resistance to EGFR-targeted therapies in cancer","volume":"19","author":"Chong","year":"2013","journal-title":"Nat Med"},{"issue":"Suppl. 4","key":"10.1016\/j.ejca.2018.07.123_bib31","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0959-8049(01)00233-7","article-title":"The EGFR as a target for anticancer therapy\u2013focus on cetuximab","volume":"37","author":"Baselga","year":"2001","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2018.07.123_bib32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tcb.2015.12.006","article-title":"Stress-induced EGFR trafficking: mechanisms, functions, and therapeutic implications","volume":"26","author":"Tan","year":"2016","journal-title":"Trends Cell Biol"},{"issue":"5","key":"10.1016\/j.ejca.2018.07.123_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.devcel.2016.05.005","article-title":"Annexin A1 tethers membrane contact sites that mediate ER to endosome cholesterol transport","volume":"37","author":"Eden","year":"2016","journal-title":"Dev Cell"},{"issue":"1","key":"10.1016\/j.ejca.2018.07.123_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.emboj.7600759","article-title":"EGF stimulates annexin 1-dependent inward vesiculation in a multivesicular endosome subpopulation","volume":"25","author":"White","year":"2006","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.ejca.2018.07.123_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/imr.12013","article-title":"Transfer of extracellular vesicles during immune cell-cell interactions","volume":"251","author":"Guti\u00e9rrez-V\u00e1zquez","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ejca.2018.07.123_bib36","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/ncomms15016","article-title":"Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ejca.2018.07.123_bib37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/07357907.2013.789905","article-title":"Epidermal growth factor receptor-containing exosomes induce tumor-specific regulatory T cells","volume":"31","author":"Huang","year":"2013","journal-title":"Cancer Investig"},{"issue":"10","key":"10.1016\/j.ejca.2018.07.123_bib38","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1038\/bjc.2014.521","article-title":"Differential response of head and neck cancer cell lines to TRAIL or Smac mimetics is associated with the cellular levels and activity of caspase-8 and caspase-10","volume":"111","author":"Raulf","year":"2014","journal-title":"Br J Cancer"},{"issue":"22","key":"10.1016\/j.ejca.2018.07.123_bib39","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1093\/bioinformatics\/btv377","article-title":"Alternative preprocessing of RNA-sequencing data in the cancer genome atlas leads to improved analysis results","volume":"31","author":"Rahman","year":"2015","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.ejca.2018.07.123_bib40","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.ejca.2018.07.123_bib41","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.nano.2011.04.003","article-title":"Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis","volume":"7","author":"Dragovic","year":"2011","journal-title":"Nanomedicine (Lond)"},{"issue":"15","key":"10.1016\/j.ejca.2018.07.123_bib42","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jacc.2015.02.026","article-title":"Plasma exosomes protect the myocardium from ischemia-reperfusion injury","volume":"65","author":"Vicencio","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ejca.2018.07.123_bib43","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/ar.21176","article-title":"Nuclear localization of annexin A1 correlates with advanced disease and peritoneal dissemination in patients with gastric carcinoma","volume":"293","author":"Zhu","year":"2010","journal-title":"Anat Rec (Hoboken)"},{"issue":"23","key":"10.1016\/j.ejca.2018.07.123_bib44","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1002\/cncr.27565","article-title":"Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor\/extracellular signal-regulated kinase\/integrin beta-1-binding protein 1 pathway","volume":"118","author":"Cheng","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2018.07.123_bib45","first-page":"237","article-title":"The growth-response of human tumor-cell lines expressing the EGF receptor to treatment with EGF and or mabs that block ligand-binding","volume":"3","author":"Modjtahedi","year":"1993","journal-title":"Int J Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2018.07.123_bib46","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1016\/j.yexcr.2008.07.013","article-title":"Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells","volume":"314","author":"Perez-Torres","year":"2008","journal-title":"Exp Cell Res"},{"issue":"19","key":"10.1016\/j.ejca.2018.07.123_bib47","doi-asserted-by":"crossref","first-page":"27007","DOI":"10.18632\/oncotarget.8875","article-title":"ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and c-Myc to reduce breast cancer proliferation","volume":"7","author":"Yuan","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ejca.2018.07.123_bib48","doi-asserted-by":"crossref","first-page":"e0175443","DOI":"10.1371\/journal.pone.0175443","article-title":"The ET-1-mediated carbonylation and degradation of ANXA1 induce inflammatory phenotype and proliferation of pulmonary artery smooth muscle cells in HPS","volume":"12","author":"He","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ejca.2018.07.123_bib49","first-page":"5214","article-title":"ANXA1 affects cell proliferation, invasion and epithelial-mesenchymal transition of oral squamous cell carcinoma","volume":"14","author":"Wan","year":"2017","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1016\/j.ejca.2018.07.123_bib50","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1096\/fj.06-7464rev","article-title":"Annexin 1: the new face of an old molecule","volume":"21","author":"Lim","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.ejca.2018.07.123_bib51","first-page":"1","article-title":"Tumour microenvironment on mitochondrial dynamics and chemoresistance in cancer","author":"Han","year":"2018","journal-title":"Free Radic Res"},{"issue":"2","key":"10.1016\/j.ejca.2018.07.123_bib52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11523-018-0555-4","article-title":"Tumor hypoxia as an enhancer of inflammation-mediated metastasis: emerging therapeutic strategies","volume":"13","author":"DiGiacomo","year":"2018","journal-title":"Target Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2018.07.123_bib53","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/eji.201242709","article-title":"Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM-1 expression","volume":"43","author":"Pierobon","year":"2013","journal-title":"Eur J Immunol"},{"issue":"46","key":"10.1016\/j.ejca.2018.07.123_bib54","doi-asserted-by":"crossref","first-page":"18351","DOI":"10.1073\/pnas.1318345110","article-title":"Hypoxia and inflammation are two sides of the same coin","volume":"110","author":"Bartels","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.ejca.2018.07.123_bib55","doi-asserted-by":"crossref","first-page":"e0187310","DOI":"10.1371\/journal.pone.0187310","article-title":"Evaluation of miRNA-196a2 and apoptosis-related target genes: ANXA1, DFFA and PDCD4 expression in gastrointestinal cancer patients: a pilot study","volume":"12","author":"Fawzy","year":"2017","journal-title":"PLoS One"},{"issue":"52","key":"10.1016\/j.ejca.2018.07.123_bib56","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1038\/onc.2008.256","article-title":"MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers","volume":"27","author":"Luthra","year":"2008","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.ejca.2018.07.123_bib57","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00432-008-0530-z","article-title":"Down-regulation of plasma membranous Annexin A1 protein expression in premalignant and malignant lesions of the oral cavity: correlation with epithelial differentiation","volume":"135","author":"Nomura","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2018.07.123_bib58","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2559.2008.03186.x","article-title":"Annexin A1 subcellular expression in laryngeal squamous cell carcinoma","volume":"53","author":"Alves","year":"2008","journal-title":"Histopathology"},{"issue":"42","key":"10.1016\/j.ejca.2018.07.123_bib59","doi-asserted-by":"crossref","first-page":"17886","DOI":"10.1073\/pnas.0901324106","article-title":"Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice","volume":"106","author":"Yi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.ejca.2018.07.123_bib60","doi-asserted-by":"crossref","first-page":"e111317","DOI":"10.1371\/journal.pone.0111317","article-title":"Inflammation and cancer: role of annexin A1 and FPR2\/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma","volume":"9","author":"Gastardelo","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ejca.2018.07.123_bib61","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/emmm.201000095","article-title":"Annexin A1 attenuates EMT and metastatic potential in breast cancer","volume":"2","author":"Maschler","year":"2010","journal-title":"EMBO Mol Med"},{"issue":"28","key":"10.1016\/j.ejca.2018.07.123_bib62","doi-asserted-by":"crossref","first-page":"25076","DOI":"10.18632\/oncotarget.4725","article-title":"Annexin A1 is involved in the acquisition and maintenance of a stem cell-like\/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid","volume":"6","author":"Bizzarro","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ejca.2018.07.123_bib63","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-015-3529-6","article-title":"RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway","volume":"153","author":"Zhang","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"1\u20132","key":"10.1016\/j.ejca.2018.07.123_bib64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11010-015-2584-y","article-title":"Cell surface interaction of annexin A2 and galectin-3 modulates epidermal growth factor receptor signaling in Her-2 negative breast cancer cells","volume":"411","author":"Shetty","year":"2016","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"10.1016\/j.ejca.2018.07.123_bib65","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3892\/or.2013.2545","article-title":"The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia","volume":"30","author":"Ries","year":"2013","journal-title":"Oncol Rep"},{"issue":"5","key":"10.1016\/j.ejca.2018.07.123_bib66","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.oraloncology.2004.12.010","article-title":"Profiling EGFR activity in head and neck squamous cell carcinoma by using a novel layered membrane Western blot technology","volume":"41","author":"Patel","year":"2005","journal-title":"Oral Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2018.07.123_bib67","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/PAI.0000000000000437","article-title":"Assessment of EGFR and ERBB2 (HER2) in gastric and gastroesophageal carcinomas: EGFR amplification is associated with a worse prognosis in early stage and well to moderately differentiated carcinoma","volume":"26","author":"Liao","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"8","key":"10.1016\/j.ejca.2018.07.123_bib68","doi-asserted-by":"crossref","first-page":"9017","DOI":"10.18632\/oncotarget.7029","article-title":"EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2018.07.123_bib69","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1186\/s12885-015-1977-3","article-title":"High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers","volume":"15","author":"Jacot","year":"2015","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2018.07.123_bib70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02893450","article-title":"Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas","volume":"12","author":"Hiraishi","year":"2006","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"10.1016\/j.ejca.2018.07.123_bib71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13046-016-0422-z","article-title":"Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression","volume":"35","author":"Gao","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ejca.2018.07.123_bib72","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3892\/ol.2016.4883","article-title":"Enhancing chemosensitivity in oral squamous cell carcinoma by lentivirus vector-mediated RNA interference targeting EGFR and MRP2","volume":"12","author":"Chen","year":"2016","journal-title":"Oncol Lett"},{"issue":"10","key":"10.1016\/j.ejca.2018.07.123_bib73","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1349-7006.2006.00287.x","article-title":"Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma","volume":"97","author":"Nozawa","year":"2006","journal-title":"Cancer Sci"},{"issue":"8","key":"10.1016\/j.ejca.2018.07.123_bib74","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2217\/nnm-2015-0009","article-title":"Cetuximab treatment alters the content of extracellular vesicles released from tumor cells","volume":"11","author":"van Dommelen","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.ejca.2018.07.123_bib75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biocel.2014.03.014","article-title":"Interdependent epidermal growth factor receptor signalling and trafficking","volume":"51","author":"Jones","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"10.1016\/j.ejca.2018.07.123_bib76","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/odi.12087","article-title":"Phosphorylated EGFR at tyrosine 1173 correlates with poor prognosis in oral squamous cell carcinomas","volume":"20","author":"Monteiro","year":"2014","journal-title":"Oral Dis"},{"issue":"11","key":"10.1016\/j.ejca.2018.07.123_bib77","doi-asserted-by":"crossref","first-page":"967","DOI":"10.4161\/cbt.20991","article-title":"pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlations","volume":"13","author":"Aquino","year":"2012","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"10.1016\/j.ejca.2018.07.123_bib78","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00784-015-1541-1","article-title":"Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas","volume":"20","author":"Schneider","year":"2016","journal-title":"Clin Oral Investig"},{"issue":"2","key":"10.1016\/j.ejca.2018.07.123_bib79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","article-title":"Current knowledge on exosome biogenesis and release","volume":"75","author":"Hessvik","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"10.1016\/j.ejca.2018.07.123_bib80","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.3892\/or.2016.5066","article-title":"Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma","volume":"36","author":"Matsumoto","year":"2016","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.ejca.2018.07.123_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/2326-6066.CIR-14-0209","article-title":"Tumors: wounds that do not heal-redux","volume":"3","author":"Dvorak","year":"2015","journal-title":"Cancer Immunol Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491831092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491831092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T03:11:40Z","timestamp":1717297900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980491831092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":81,"alternative-id":["S095980491831092X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2018.07.123","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Annexin A1 regulates EGFR activity and alters EGFR-containing tumour-derived exosomes in head and\u00a0neck cancers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2018.07.123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}